Research conducted at the Berman-Gund Laboratory for the Study of Retinal Degenerations at Harvard Medical School has shown that phenotypic differences recorded in the clinical assessment of Bardet Biedl syndrome (BBS) patients may help guide genetic testing and counseling for BBS patients. Matching particular phenotypes to genetic information may provide clear clinical applicability in managing genetic testing and clinical care.